1.Scrip code : 533227
Name : Asian Hotels (East) Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement This is to inform you that at the Board meeting of even date, the Board, upon considering the recommendation of the Audit Committee, has considered and approved a Scheme of Arrangement for the demerger of the Company’s [Demerged Company] division namely ‘Investments including Investment in Hotel (South)’ [Investment Division] into Robust Hotels Private Limited, a wholly owned subsidiary of the Company [RHPL/Resulting Company] in terms of Section 230-232, other applicable provisions of the Companies Act, 2013 and the Rules made thereunder as a going concern in compliance with Section 2(19AA) of Income Tax Act, 1961 [Scheme]. Appointed Date of the proposed Scheme is business opening hours on 1st April, 2020.
2.Scrip code : 533285
Name : RDB Realty & Infrastructure Limited
Subject : Announcement under Regulation 30 (LODR)-Scheme of Arrangement Dear Sir/Madam, In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Circular No. CIR/CFD/CMD/4/2015 dated 9th September, 2015 issued by the SEBI, we hereby inform you that the Board of Directors of RDB Realty & Infrastructure Limited at its Meeting held today, i.e. on 16th day of September, 2019 has, on the recommendation of the Audit Committee, approved the Scheme of Arrangement for Demerger between RDB Realty & Infrastructure Limited (‘RRIL’) and RDB Real Estate Constructions Limited (‘RRECL’) and their respective shareholders for demerger of Realty division of RRIL, under Sections 230 to 232 of the Companies Act, 2013, subject to receipt of approvals from shareholders and creditors of the Company as may be directed by the National Company Law Tribunal bench at Kolkata, BSE Limited, the Calcutta Stock Exchange Limited, the SEBI and approval of other regulatory or statutory authorities as may be required.
3.Scrip code : 531146
Name : Medicamen Biotech Ltd.
Subject : Announcement under Regulation 30 (LODR)-Acquisition
In accordance with Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby inform you that the Company has entered into the following Agreements: 1. Vide an agreement dated 16.09.2019, acquisition of the entire (100%) Equity Share Capital of OPAL Pharmaceuticals Pty Ltd (a company incorporated in Australia, hereinafter referred to as ‘OPAL’) (the ‘Target Company’) from its existing shareholders for a consideration aggregating up to (AU) $ 420,000. On completion of all the closing formalities, the Target Company will become a 100% Subsidiary of the Company. 2. Subsequently, vide an agreement dated 17.09.2019, disposal/sale of 25% Equity Share Capital of OPAL held by the Company to Baxyran Healthcare Private Limited (the ‘Buyer’) for a consideration of Rs. 51, 53,400/- Only . Therefore, post the aforesaid transfer, OPAL shall cease to be Company’s WOS and the Company will become holder of 75% Equity Share Capital in the said subsidiary.
4.Scrip code : 532978
Name : Bajaj Finserv Limited
Subject : Announcement under Regulation 30 (LODR)-Allotment
Pursuant to Regulation 30 of the SEBI LODR, 2015, this is to inform you that the Board of Directors of Bajaj Finserv Limited at its meeting held on 17 September 2019 i.e. today has issued and allotted 1,179 rights equity shares of the Company which were earlier kept in abeyance and arising out of rights issue made by the Company in 2012. The meeting concluded at 1.30 p.m. Kindly take the above on record.